Stockreport

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements [Yahoo! Finance]

CNS Pharmaceuticals, Inc.  (CNSP) 
PDF Berubicin study enrollment completed; Topline data expected in first half of 2025 Clinical progress represents important steps towards Berubicin potentially addressin [Read more]